Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Affect Disord. 2011 Mar;129(1-3):321-6. doi: 10.1016/j.jad.2010.07.036.

Differential outcome of bipolar patients receiving antidepressant monotherapy versus combination with an antimanic drug.

Author information

  • 1Bipolar Disorders Program, Institute of Neuroscience, Hospital Clinic Barcelona, IDIBAPS, CIBERSAM, University of Barcelona, Catalonia, Spain.

Abstract

INTRODUCTION:

Despite antidepressants are widely used in treating bipolar depression, there is much debate about their utility and their potential dangers, involving mood switches and suicidality. Our hypothesis was that the pattern of initial antidepressant prescription, i.e., alone (AM) or in combination with stabilizers (AC) might impact the long-term outcome of patients with bipolar disorder (BP). We aimed to test this hypothesis and to identify outcome measures that could be predicted by initial AM or AC treatment in patients with BP.

METHODS:

We included 95 patients with DSM-IV BP from a pool of 138 patients following a BP program. Patients were rated for initial AM vs. AC treatment when they were first seen in primary care and subdivided into two groups accordingly. Differences in their clinical course were sought investigating course both retrospectively and prospectively (mean follow-up 10 years). Primary outcome measures comprised suicidality and switch rate.

RESULTS:

There were significantly more patients who switched in the AM group than in the AC group. The number of suicide attempts was higher in the AM group. Significance was retained after performing logistic regression.

LIMITATIONS:

Sample size was small and severe BP patients might be overrepresented in this sample.

DISCUSSION:

Initial AM treatment of patients subsequently diagnosed as BP may entrain a course characterized by higher proneness to switch and suicidal behaviour. Accurate initial diagnosis of bipolar depression should prompt combined treatment with antimanic drugs.

Copyright © 2010 Elsevier B.V. All rights reserved.

PMID:
20817267
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk